{
  "completed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9
  ],
  "results": [
    {
      "example_idx": 0,
      "dataset_id": "1511",
      "question": "What is a lockdown?",
      "ground_truth_answer": "A lockdown is the implementation of strict restrictions and measures to limit people's movement and activities in order to control the spread of infections, such as the one mentioned in the given context.",
      "generated_response": "<think>\nOkay, the user is asking, \"What is a lockdown?\" Let me look at the provided context to find the answer.\n\nLooking at the context, there are multiple entries with the title \"Estimating the number of infections and the impact of non-\" and the passage \"Lockdown\" or \"banned Implemented with lockdown.57 24/3/2020\". Hmm, the context seems a bit fragmented. The titles are cut off, and the passages are either just the word \"Lockdown\" or a sentence that starts with \"banned Implemented with lockdown.57 24/3/2020\". \n\nSince the context is limited and not very detailed, I need to infer based on common knowledge. A lockdown typically refers to a government-imposed restriction on movement and activities to control the spread of a disease, like during a pandemic. The mention of estimating infections and lockdown in the titles suggests that the context is related to public health measures. The date 24/3/2020 might refer to when a lockdown was implemented, possibly in a specific country around the time of the COVID-19 pandemic.\n\nGiven that the provided context doesn't have a clear definition, but the question is general, I should provide a standard definition of a lockdown. However, I need to check if the context gives any specific details. The part \"banned Implemented with lockdown.57\" might be a typo or part of a larger dataset, but without more information, it's hard to use that. \n\nSo, the answer should be a general explanation of a lockdown as a public health measure, possibly referencing the context's mention of estimating infections and the date, which aligns with the early days of the COVID-19 lockdowns. I should make sure to mention that the context refers to the impact of lockdowns on infection numbers, even though the details are sparse.\n</think>\n\nA **lockdown** is a public health measure implemented by governments to restrict movement and gatherings of people, typically during a pandemic or outbreak, to slow the spread of infectious diseases. It often involves closing non-essential businesses, schools, and public spaces, and limiting travel to essential activities only. The context provided references the implementation of lockdowns (e.g., \"banned Implemented with lockdown.57 24/3/2020\") as part of efforts to estimate infection numbers and assess their impact, likely in response",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: banned Implemented with lockdown.57 24/3/2020"
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 1,
      "dataset_id": "1085",
      "question": "What complications are associated with CHIKV?",
      "ground_truth_answer": "Complications associated with CHIKV include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the complications associated with CHIKV, which I know stands for Chikungunya virus. I need to look through the provided context passages to find all the mentioned complications.\n\nFirst, in the first passage, it lists several complications from most common to least. Let me check that again. It says respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure. So those are the main ones.\n\nThen, looking at the other passages about neonatal transmission. The third passage mentions that neonates could get mengoencephalitis (probably a typo for meningoencephalitis). Also, the fourth passage talks about encephalitis due to vertical transmission. So encephalitis and meningoencephalitis are complications in newborns.\n\nAdditionally, the third passage mentions that neonates were symptomatic with common CHIKF symptoms. CHIKF is Chikungunya fever, so maybe the common symptoms like fever, rash, joint pain, but the question is about complications. However, the specific complications in neonates include encephalitis and possibly others from the vertical transmission.\n\nSo compiling all the complications from all passages: respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other CNS problems, kidney failure, and encephalitis in neonates. Also, the high morbidity and mortality in certain groups like the elderly and those with underlying conditions. But the question is specifically about complications, so the list from the first passage plus the neonatal encephalitis from the other studies.\n\nI need to make sure I didn't miss any. Let me check again. The first passage lists complications in order: respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other CNS problems, kidney failure. Then the neonatal cases add encephalitis. Also, the first passage mentions that severe cases in adults can lead to death, but that's more of an outcome rather than a complication. The answer should list all the complications mentioned, so combining all the points from the passages.\n</think>\n\nThe complications associated with Chikungunya virus (CHIKV) include:  \n1. **Respiratory failure**  \n2. **Card",
      "retrieved_chunks": [
        "Title: Chikungunya: A Potentially Emerging Epidemic?\nPassage: More than 50% of patients who suffer from severe CHIKF are over 65 y old, and more than 33% of them die. Most adults who suffer from severe CHIKF have underlying medical conditions . The other group that is disproportionately affected by severe CHIKV is children. Other complications associated with CHIKV, from most common to least common, include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure .\n\nTitle: Chikungunya: A Potentially Emerging Epidemic?\nPassage: and complications.\n\nTitle: Chikungunya: A Potentially Emerging Epidemic?\nPassage: During the 2005-2006 La Reunion Island outbreaks, Ramful et al. discovered that mothers could transmit CHIKV to their progeny during the perinatal period , and it is associated with a high degree of morbidity. By mean Day 4 of life, all of the neonates were symptomatic for CHIKV, exhibiting common CHIKF symptoms. Six neonates were confirmed to have contracted CHIKV and developed mengoencephalitis. Of those mothers who, during the La Reunion Island epidemic, were infected long before delivery, only three fetal deaths were reported . Ramful et al. theorized that motherto-child transmission most likely happens transplacentally shortly before delivery .\n\nTitle: Chikungunya: A Potentially Emerging Epidemic?\nPassage: A similar study by Gerardin et al. reported nineteen cases of neonatal infection associated with intrapartum maternal viremia that progressed to develop encephalitis owing to vertical transmission from infected mothers ."
      ],
      "computed_relevance": 0.2222222222222222,
      "computed_utilization": 0.3888888888888889,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 2,
      "dataset_id": "1248",
      "question": "What does Clade A contain?",
      "ground_truth_answer": "Clade A contains 1,889 viruses from 34 countries collected from 2010 to the present.",
      "generated_response": "<think>\nOkay, let's see. The user is asking what Clade A contains based on the provided context. First, I need to look through the given passages to find any mention of Clade A. \n\nLooking at the first passage, the title mentions the 1A swine lineage. The passage says that the 1A lineage has 1,889 viruses from 34 countries collected from 2010 to the present. It also talks about refining the classification into three second-order divisions. However, there's no mention of Clade A here. The second passage is about the 1C lineage, which includes viruses from China and South Korea. The third passage is about the 1B human seasonal lineage. The fourth passage mentions seven clades but doesn't specify Clade A.\n\nWait, the user is asking about Clade A, but in the provided passages, the lineages are referred to as 1A, 1B, 1C, etc. There's no mention of a Clade A in the text. The first passage refers to the 1A lineage, which is divided into three second-order clades like 1A.1, 1A.1.1, etc. But the question is about Clade A, not 1A. \n\nSince none of the passages mention Clade A specifically, and all references are to lineages like 1A, 1B, 1C, it's possible that the user might have confused Clade A with the 1A lineage. However, the answer should be based strictly on the provided context. Since there's no information about Clade A in the passages, the correct answer would be that there's no information provided about Clade A. The answer should reflect that the context doesn't mention Clade A, only lineages like 1A, 1B, 1C.\n</think>\n\nThe provided context does not mention a specific \"Clade A.\" Instead, it discusses various lineages such as **1A**, **1B**, and **1C** swine influenza A virus lineages. For example:  \n- The **1A lineage** contains 1,889 viruses from 34 countries (2010\u2013present).  \n- The **1C lineage** includes 315 viruses from China and South Korea.  \n- The **1B lineage** refers to human seasonal",
      "retrieved_chunks": [
        "Title: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1A swine lineage. The 1A lineage contained 1,889 viruses from 34 countries collected from 2010 to the present . According to our nomenclature rules, we refined the classification of 1A viruses into three second-order divisions, each of which corresponds to earlier, regional classifica- Table 2 . Each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade, although some minor exceptions were made when all other clade-defining criteria were met and mitigating circumstances supported the exception. Within-clade exceptions were made for the first-order 1A.1 and the extensive 1A.1.1 second-order clade\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1C swine lineage. The 1C lineage consisted of 315 viruses from 14 countries collected from 2010 to the present in China and South Korea. Avian H1 HA sequences were generally restricted to two monophyletic clades distinct from, but sister to, the 1C swine viruses: these HA sequences were defined as \"Other-Avian.\" The within-and between-clade APDs are presented in Table 4 . For the most part, each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade. The one within-clade exception in this lineage was 1C.2 , which had multiple monophyletic\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: The 1B human seasonal lineage within-and between-clade APDs are presented in Table 3 . For the most part, each clade had an APD of \u03fe7% from other clades and almost all had an APD of \u03fd7% within the clade. The within-clade exceptions were the 1B.1 and 1B.2 clades . The 1B.1 second-order clade had too few representative sequences to calculate genetic distance, and 1B.2 represented multiple monophyletic clades that individually did not meet our criteria for further division. Similarly, the extensive 1B.1.1 clade did not meet criteria for further splitting. The exception to the between-clade threshold was associated with clades\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: were placed into seven clades. The numerically dominant clades reflected intensive surveillance in the United States , investigator sequencing efforts in Canada , and the rapid dissemination of the 2009 H1N1 pandemic virus across global swine populations . Similarly, coordinated surveillance in Europe and Asia captured two primary clades of 1C Eurasian avian lineage currently circulating in the two continents."
      ],
      "computed_relevance": 0.25,
      "computed_utilization": 0.25,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 1.0,
      "gt_utilization": 0.041666666666666664,
      "gt_completeness": 0.041666666666666664,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 3,
      "dataset_id": "1696",
      "question": "How do the S1 subunits compare with that of SARS-likeCOV and human SARS-COV?",
      "ground_truth_answer": "The S1 subunit of 2019-nCoV shares around 70% identity with those of two bat SARS-like CoVs and human SARS-CoV.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the S1 subunits of the 2019-nCoV compare to those of SARS-like CoVs and human SARS-CoV. I need to look through the provided context to find relevant information.\n\nFirst, looking at the first passage: It mentions that the S1 subunit has a signal peptide, N-terminal domain, and receptor-binding domain (RBD). Then it says the S2 subunit is highly conserved with 99% identity, but the question is about S1. The next part says the S1 subunit of 2019-nCoV shares around 70% identity with the bat SARS-like CoVs and human SARS-CoV. Also, the core domain of RBD is highly conserved, but the amino acid differences are in the external subdomain, which interacts with the host receptor. \n\nAnother part from the third title mentions that the external subdomain of the Spike's RBD in 2019-nCoV shares only 40% identity with other SARS-related coronaviruses. Wait, but the first passage said 70% for the S1 subunit. Maybe there's a difference between the whole S1 and specific regions like RBD. The first passage says the core RBD is conserved, but the external part has differences. The third passage emphasizes the 40% for the external subdomain. \n\nSo putting it together: The S1 subunit as a whole has about 70% identity with SARS-like and human SARS-CoV, but the RBD's external part (which is part of S1) is less conserved, around 40%. The core RBD is more conserved. Also, the S1 subunit's differences are in the external subdomain responsible for host interaction. This suggests that while there's some similarity, the receptor-binding part has variations that might affect host interaction and transmission. The answer should mention the 70% identity overall for S1, but note the lower 40% in the external RBD subdomain. Also, the core RBD is conserved. Need to check if the 40% is part of the S1's RBD or another part. The third passage says the external subdomain of the RBD (which is part of S1) has 4",
      "retrieved_chunks": [
        "Title: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: Spike glycoprotein comprised of S1 and S2 subunits. The S1 subunit contains a signal peptide, followed by an N-terminal domain and receptor-binding domain , while the S2 subunit contains conserved fusion peptide , heptad repeat 1 and 2, transmembrane domain , and cytoplasmic domain . We found that the S2 subunit of 2019-nCoV is highly conserved and shares 99% identity with those of the two bat SARS-like CoVs and human SARS-CoV . Thus the broad spectrum antiviral peptides against S2 would be an important preventive and treatment modality for testing in animal models before clinical trials . Though the S1\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: subunit of 2019-nCoV shares around 70% identity to that of the two bat SARS-like CoVs and human SARS-CoV ), the core domain of RBD are highly conserved ). Most of the amino acid differences of RBD are located in the external subdomain, which is responsible for the direct interaction with the host receptor. Further investigation of this soluble variable external subdomain region will reveal its receptor usage, interspecies transmission and pathogenesis. Unlike 2019-nCoV and human SARS-CoV, most known bat SARSr-CoVs have two stretches of deletions in the spike receptor binding domain when compared with that of human SARS-CoV. But some\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: bat, civet and human SARS coronaviruses. However, the external subdomain of Spike\u2019s receptor binding domain of 2019-nCoV shares only 40% amino acid identity with other SARS-related coronaviruses. Remarkably, its orf3b encodes a completely novel short protein. Furthermore, its new orf8 likely encodes a secreted protein with an alpha-helix, following with a beta-sheet containing six strands. Learning from the roles of civet in SARS and camel in MERS, hunting for the animal source of 2019-nCoV and its more ancestral virus would be important for understanding the origin and evolution of this novel lineage B betacoronavirus. These findings provide the basis for\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: As shown in Figure 7 , the SARS-CoV 5 \u2032 -UTR contains SL1, SL2, SL3, SL4, S5, SL5A, SL5B, SL5C, SL6, SL7, and SL8. The SL3 contains trans-cis motif . The SL1, SL2, SL3, SL4, S5, SL5A, SL5B, and SL5C structures were similar among the 2019-nCoV, human SARS-CoV and the bat SARS-related ZC45. In the 2019-nCoV, part of the S5 found was inside Figure 7 Continued the orf1a/b , which was similar to SARS-CoV. In bat SARS-related CoV ZC45, the S5 was not found inside orf1a/b. The 2019-nCoV had the same SL6, SL7, and SL8 as SARS-CoV, and an additional"
      ],
      "computed_relevance": 0.15789473684210525,
      "computed_utilization": 0.15789473684210525,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.12,
      "gt_utilization": 0.04,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 4,
      "dataset_id": "669",
      "question": "What is Bacillus subtilis?",
      "ground_truth_answer": "Bacillus subtilis is a species of bacteria that has been shown to be effective in the prevention and/or treatment of intestinal diseases such as diarrhea, colitis, irritable bowel syndrome, irritable bowel disease, and colorectal cancer. It is also a part of the normal intestinal microbiome and has been found in the healthy human gastrointestinal tract. Bacillus subtilis produces surfactins, fengycins, and iturins, which have antimicrobial and antiviral properties.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is Bacillus subtilis?\" I need to base my answer on the provided context.\n\nFirst, I'll go through each of the passages to gather relevant information. \n\nIn the first passage, it mentions that B. subtilis is a probiotic used to treat intestinal diseases like colitis. It helps restore gut microflora by increasing beneficial bacteria and decreasing harmful ones. It also maintains gut barrier integrity and reduces inflammation. The study by Bene et al., 2017 is cited here.\n\nThe second passage talks about Bacillus and Lactobacillus species being in traditional fermented foods and commercial probiotics. Specific products like Enterogermina and Biosubtyl are listed. However, it's more about their use in food and probiotics in general, but since B. subtilis is part of Bacillus genus, this context is relevant.\n\nThe third passage discusses Bacillus spp. being part of the gut microbiome, not just transient. It mentions that they are adapted to the gastrointestinal tract (GIT) and colonize there. This helps establish that B. subtilis isn't just passing through but is a resident microbe in the gut.\n\nThe fourth passage details the substances produced by B. subtilis: surfactins, fengycins, and iturins. It explains that surfactins have antimicrobial and antiviral properties, protect against other bacteria's vesicles, and modulate inflammation by affecting cytokines.\n\nPutting this together, Bacillus subtilis is a probiotic bacterium that's part of the gut microbiome. It's used in treating intestinal issues, helps balance gut flora, produces beneficial compounds, and has anti-inflammatory effects. It's found in probiotics and fermented foods. Also, it's adapted to live in the gut, not just transient. The key points are its role as a probiotic, its mechanisms (producing lipopeptides), and its effects on gut health.\n\nI need to make sure the answer includes all these aspects without being too technical. Also, mention the specific products it's in, but maybe just a couple examples. Highlight the secretome (the substances it produces) and their functions. Also note that it's part of the normal gut microbiome now, contrary to previous beliefs. Avoid any markdown and keep it concise.\n</think>\n\nBacillus subtilis is a probiotic bacter",
      "retrieved_chunks": [
        "Title: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: The efficacy of Lactobacillus and Bacillus in the prevention and/or treatment of intestinal diseases such as diarrhea, colitis, irritable bowel syndrome, irritable bowel disease, and colorectal cancer was demonstrated . In particular, treatment of colorectal colitis in mice with probiotic B. subtilis restored balance in gut microflora: beneficial species of Bifidobacterium, Lactobacillus, and Butyricicoccus spp. were increased, while gut damage-promoting species of Acinetobacter sp., Ruminococcus sp., Clostridium spp., and Veillonella sp. were decreased . B. subtilis also retained gut barrier integrity, decreased the endotoxin concentration and reduced gut inflammation Bene et al., 2017) . Sporulation of B. subtilis plays a\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: Historically, species of Lactobacillus and Bacillus are found in the traditional fermented food products possessing beneficial properties for the intestinal function and are widely used as components of commercially available probiotics: DE111 , Enterogermina , Biosubtyl , Biosporin , BioSpora , Blicheni and Zhengchangsheng , GanedenBC 30 , Lactobacterin , HOWARU or DR20 , Yakult , PCC . In food industry, lactobacilli are applied as starter cultures in the production of fermented milk products, cheese, sausages, bread, kimchi, pickles, and yogurts, the latter accounting for the largest share of sales . The administration of probiotics has been shown to favorably\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: For a long time, the representatives of Bacillus genus, unlike the species of Lactobacillus, were not considered as a part of the normal intestinal microbiome. Being isolated from feces, Bacillus spp. as soil microorganisms were considered transient. Recent studies show that they are present in the GIT in the amounts significantly higher than what can be explained by their ingestion with food only. Bacillus spp. have been isolated from the healthy human GIT, where they are well-adapted and are more colonizing than transient . In environment, the vegetative forms of Bacillus are present usually near decomposing plants and in their\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: B. subtilis produces surfactins, fengycins and iturins in a ratio of 6:37:57 . The less abundant surfactins unlike other types of Bacillus lipopeptides exhibit a broad range of antimicrobial activities and possess antiviral action . They protect bacilli against extracellular antibiotic-containing vesicles of other species and inhibit phospholipase A2 resulting in subsequent downregulation of pro-inflammatory cytokines and upregulation of anti-inflammatory cytokines ."
      ],
      "computed_relevance": 0.35,
      "computed_utilization": 0.5,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.4090909090909091,
      "gt_utilization": 0.18181818181818182,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 5,
      "dataset_id": "81",
      "question": "What past research has been done on severe, single-wave pandemics?",
      "ground_truth_answer": "The given passages do not specifically mention past research on severe, single-wave pandemics. However, they do reference research on pandemic strains, influenza spread, and pandemic severity categories, as well as the origins and circulation of specific pandemic influenza strains.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about past research on severe, single-wave pandemics. I need to look through the provided contexts to find relevant information.\n\nFirst, looking at the first context titled \"The origins of the great pandemic,\" it mentions the 1889 pandemic with three major waves from 1889 to 1892, specifically noting the 1892 wave as the most intense. The passage also speculates about herald waves of the 1918 pandemic possibly starting as early as 1915. However, this seems to discuss multi-wave pandemics rather than single-wave ones. But there's a mention of viruses circulating in early 1918 before the recognized pandemic, which might relate to understanding pandemic origins, though not directly about single-wave.\n\nNext, the second context about the 2009 pandemic in Hong Kong talks about convalescent plasma treatment and research on the epidemiology of pH1N1. They confirmed the origins of the 2009 strain through local surveillance. This is more about mitigation strategies and origins rather than the structure of the pandemic waves.\n\nThe third context is an economic analysis considering five pandemic severity categories. It references studies using simulation models for mitigation strategies, varying intervention combinations, and data from the 2009 pandemic. While this involves pandemic modeling, it's focused on economic analysis and multi-faceted interventions, not specifically single-wave pandemics.\n\nThe fourth context discusses the 2009 pH1N1 pandemic in Taiwan, using a Richards model variation to analyze multiple waves. The passage mentions distinguishing between two types of turning points in multi-wave epidemics. This directly addresses multi-wave patterns but not single-wave.\n\nPutting this together, the contexts provided don't explicitly mention research on single-wave pandemics. They mostly discuss multi-wave pandemics (like 1889, 1918, 2009) and related studies on origins, mitigation, and economic impacts. The user is asking about severe, single-wave pandemics, which isn't directly addressed in the given contexts. However, the 1889 pandemic had multiple waves, so maybe the user is looking for any mention of single-wave. Since none of the contexts discuss single-wave pandemics, the answer should state that the provided research focuses on multi-wave pandemics and related aspects, without specific mention of single-wave events",
      "retrieved_chunks": [
        "Title: The origins of the great pandemic\nPassage: Because the 1889 pandemic unfolded with three major waves worldwide from 1889 to 1892 , with the 1892 wave being the most intense, at least on the East Coast of the USA, it seems worth considering whether so-called herald waves of the 1918 pandemic might have stretched back all the way to 1915. Viruses with identical or nearly identical genome sequences to those in the fall wave were circulating in early 1918 , at a time prior to the recognition of a new pandemic. It is perhaps not so great a leap to imagine that these viruses were related to\n\nTitle: The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong\nPassage: of convalescent plasma to treat severe infections was shown to be feasible in a pandemic 57 and evidence of its effectiveness albeit from a small study should justify further studies. 56 While we focused on research into the epidemiology, impact, and control of pH1N1, much important research on pH1N1 has been carried out in other areas outside the scope of our review. To give two specific examples, local researchers confirmed the origins of the 2009 pandemic strain by comparison with a detailed local swine influenza surveillance program, 65 and performed important basic studies on pathogenesis. 66 Two sets of studies\n\nTitle: Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories\nPassage: Several related studies which also used individualbased simulation models of influenza spread coupled with costing models are those of those of Sander et al., Perlroth et al., Brown et al., and Andradottir et al. . The current study extends upon the scope of these studies in several ways: five gradations of pandemic severity are considered, more combinations of interventions are considered, social distancing interventions of varying durations are considered, and probabilities of severe health outcomes for each severity category are based on fatality, hospitalization and ICU usage data as observed from the 2009 pandemic. Also in contrast with those models,\n\nTitle: On Temporal Patterns and Circulation of Influenza Virus Strains in Taiwan, 2008-2014: Implications of 2009 pH1N1 Pandemic\nPassage: When there is more than one wave of infections, as in our current study, a variation of the Richards model can be utilized, which makes the distinction between two types of turning points ; one type which occurs at the peak incidence, and a second type which occurs in a multi-wave epidemic when the growth rate of the cumulative case number begins to increase again, indicating the beginning of the next wave."
      ],
      "computed_relevance": 0.2222222222222222,
      "computed_utilization": 0.2222222222222222,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.26666666666666666,
      "gt_utilization": 0.26666666666666666,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 6,
      "dataset_id": "1564",
      "question": "How many reported viral pneumonia?",
      "ground_truth_answer": "The passage does not provide a specific number of reported viral pneumonia cases overall. However, it mentions 2744 confirmed cases of pneumonia with 2019-nCoV infection in China, and it also mentions 77 fatal cases of pandemic H1N1v 2009 infection.",
      "generated_response": "<think>\nOkay, let's see. The user is asking \"How many reported viral pneumonia?\" based on the provided context. I need to look through each of the given passages to find any numbers related to viral pneumonia cases.\n\nFirst, the first passage is about the 2019-nCoV (which is SARS-CoV-2) infected pneumonia. It mentions 2744 confirmed cases as of January 26, 2020. That's a specific number related to viral pneumonia caused by this coronavirus. The other passages are about influenza. The second and third passages discuss bacterial co-infections in H1N1 cases and attack rates during pandemics, but they don't give specific numbers of reported cases. The fourth passage talks about pneumonia in adults with seasonal influenza but again doesn't provide a total number of cases. \n\nThe question is asking for the number of reported viral pneumonia cases. The only passage that provides a specific number is the first one regarding 2019-nCoV. The other contexts don't mention specific numbers of reported cases. So the answer should be 2744, as that's the only explicit number given for viral pneumonia in the provided texts. I need to make sure there's no other number I missed. Let me check again. The first passage says 2744 confirmed cases. The other passages don't mention numbers of reported cases, just percentages or other stats. So the answer is 2744.\n</think>\n\nThe context provided includes a report from the National Health Commission of China on January 26, 2020, stating **2,744 confirmed cases of pneumonia caused by 2019-nCoV (SARS-CoV-2)**. This is the only passage in the provided texts that explicitly reports a numerical figure for viral pneumonia cases. Other passages discuss influenza-related pneumonia but do not provide specific case counts. \n\n**Answer:** 2,744.",
      "retrieved_chunks": [
        "Title: A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)\nPassage: At 24:00 on 26 January 2020, the National Health Commission of the People's Republic of China has recorded a total of 2744 confirmed cases of pneumonia with 2019-nCoV infection from 30 provinces , including 461 severe cases and 80 deaths. A total of 51 cases have been cured and discharged. At present, 5794 suspected cases were recorded, 32,799 with close contacts to the confirmed patients have been tracked, 583 people were released from medical observation that day, and 30,453 people were still undergoing medical observation. A total of confirmed cases were reported from Hong Kong, Macao and Taiwan of China:\n\nTitle: Clinical review: Primary influenza viral pneumonia\nPassage: Bacterial co-infection, though uncommonly reported in the early stages of the 2009 H1N1 pandemic, may be more prevalent than initially thought. A recent analysis of lung specimens from 77 fatal cases of pandemic H1N1v 2009 infection found a prevalence of concurrent bacterial pneumonia in 29% of these patients . The most common coinfecting bacterial pathogens were pneumococcus, Staphylococcus aureus, and Streptococcus pyogenes, with a median duration of illness of 6 days .\n\nTitle: Clinical review: Primary influenza viral pneumonia\nPassage: age versus 6% to 9% of the adults 18 to 64 years of age and none of the children . Influenza attack rates during seasonal epidemics vary between 10% and 20% but can be much higher during pandemics. For example, an analysis of the pandemic 2009 H1N1 influenza A outbreak in La Gloria, Veracruz, found clinical attack rates of 29% in adults older than 15 years and 61% in children younger than 15 years of age . However, these rates may be different in geographic areas of low population density.\n\nTitle: Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection\u2014United States, 2005\u20132008\nPassage: Patients with pneumonia ] were significantly more likely to receive influenza antiviral therapy than patients without pneumonia ; P <0.01]."
      ],
      "computed_relevance": 0.09090909090909091,
      "computed_utilization": 0.09090909090909091,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.125,
      "gt_utilization": 0.125,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 7,
      "dataset_id": "1247",
      "question": "How has most of the analysis of MERS-CoV genetics  been performed?",
      "ground_truth_answer": "Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how most of the analysis of MERS-CoV genetics has been performed. I need to look through the provided context to find the answer.\n\nLooking at the first passage, the title mentions \"diagnostics, epidemiology and transmission.\" The first sentence says, \"Most of the analysis of MERS-CoV genetics has been performed using high throughput or 'deep' sequencing methods for complete genome deduction.\" That seems like the direct answer. The passage also mentions that MERS-CoV was the first to have such widespread use of deep sequencing for an emerging viral outbreak. \n\nI should check the other passages to see if there's any conflicting information. The second passage talks about genome analyses showing single nucleotide differences and specific regions of the genome. The third passage discusses vigilance and whole genome sequencing being used extensively. The fourth mentions genetic recombination studies. But the first passage clearly states the primary method used for the analysis. \n\nSo the answer should focus on high throughput or deep sequencing methods. The key points are that it's used for complete genome deduction and that it's a high-throughput method. The other passages support the importance of sequencing but don't contradict the first passage. Therefore, the answer is that most analysis has been done using high throughput or deep sequencing methods.\n</think>\n\nMost of the analysis of MERS-CoV genetics has been performed using **high throughput or \"deep\" sequencing methods** for complete genome deduction. This approach enabled extensive genomic studies of MERS-CoV, marking it as the first emerging viral outbreak to be widely analyzed with such techniques. Deep sequencing provided comprehensive genome coverage and repetitive measurement of nucleotide positions, facilitating detailed insights into genetic variation and evolution.",
      "retrieved_chunks": [
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction . MERS-CoV was the first subject of such widespread use of deep sequencing to study an emerging viral outbreak with global reach. The technique can produce genomic . Earlier and subsequent versions of this chart are maintained on a personal blog length coverage in a single experiment with highly repetitious measurement of each nucleotide position . Despite assays having been published early on, subgenomic sequencing, once the mainstay of viral outbreak studies, has less often been published during MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Analyses of MERS-CoV genomes have shown that most single nucleotide differences among variants were located in the last third of the genome , which encodes the spike protein and accessory proteins . At least nine MERS-CoV genomes contained amino acid substitutions in the receptor binding domain of the spike protein and codons 158 , 460 , 1020 , 1202 and 1208 bear investigation as markers of adaptive change . The spike protein had not changed in the recombinant MERS-CoV genome identified in China in 2015 but was reported to have varied at a higher rate than that for complete MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Vigilance remains important for containment since MERS-CoV is a virus with a genetic makeup that has been observed for only three years and is not stable. Among all humans reported to be infected, nearly 40 % have died. Continued laboratory testing, sequencing, analysis, timely data sharing and clear communication are essential for such vigilance to be effective. Global alignment of case definitions would further aid accurate calculation of a case fatality ratio by including subclinical case numbers. Whole genome sequencing has been used extensively to study MERS-CoV travel and variation and although it remains a tool for experts, it appears\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Two studies during 2015, one looking at Jeddah-2014 MERS-CoV variants and another looking at a variant exported from South Korea to China, have now identified signs of genetic recombination among MERS-CoV variants. While human and camel whole genome sequences have retained >99 % identity with each other, members of genetically distinct lineages can and do swap genetic material when suitable conditions and coinfections co-occur . Shared identity implies that the major source for human acquisition is the DC, rather than another animal, although more testing of other animal species is needed to confirm that conclusion. Over a month, a DC"
      ],
      "computed_relevance": 0.07142857142857142,
      "computed_utilization": 0.2857142857142857,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2857142857142857,
      "gt_utilization": 0.047619047619047616,
      "gt_completeness": 0.16666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 8,
      "dataset_id": "1129",
      "question": "How were  the spread of GFP-expressing virus-infected cells tracked?",
      "ground_truth_answer": "The spread of GFP-expressing virus-infected cells was tracked using immunofluorescence microscopy, whole-organ imaging with IVIS, flow cytometry, and inverted fluorescence microscopy.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the spread of GFP-expressing virus-infected cells was tracked. I need to look through the provided contexts to find the relevant information.\n\nFirst, looking at the first context: They mention using split-GFP-tagged viral proteins and monitoring GFP expression during passaging with immunofluorescence microscopy. But the question is about tracking the spread, so maybe this isn't the main one.\n\nSecond context: They used an inverted fluorescence microscope to monitor plates after applying an overlay. They imaged a subset of each well periodically using a CellInsight CX5 platform with a 4X objective. The settings were standardized, including exposure time. This seems like direct microscopic imaging over time to track GFP expression.\n\nThird context: Talks about using multi-photon intravital microscopy in vivo. They mention mouse lines with reporter genes like EGFP and mCherry. The strong expression allows long-term tracking without bleaching, and they can visualize small structures. This is in vivo tracking, which is different from the other contexts.\n\nFourth context: They used IVIS for whole-organ imaging of lungs ex vivo and flow cytometry to analyze infection progression in antigen-presenting cells. They observed GFP in lungs and tracked infection spread from airways to deeper areas. Also, flow cytometry was used to quantify GFP+ cells in different cell types.\n\nSo the answer should combine the methods from these contexts. The second context uses fluorescence microscopy with periodic imaging. The fourth uses IVIS and flow cytometry. The third uses intravital microscopy. The first context's method (immunofluorescence) might not be directly about tracking spread over time but monitoring during passaging.\n\nThe question is about tracking the spread, so the main methods would be fluorescence microscopy (inverted microscope with periodic imaging), IVIS for whole-organ imaging, and flow cytometry. Also, intravital microscopy for in vivo tracking. Need to mention these methods as per the contexts provided.\n</think>\n\nThe spread of GFP-expressing virus-infected cells was tracked using multiple imaging techniques. In one study, **inverted fluorescence microscopy** was employed to monitor GFP expression periodically in cell cultures, with standardized settings on a CellInsight CX5 High Content Screening Platform. For in vivo tracking, **multi-photon intravital microscopy** allowed long-term visualization of fluorescent proteins in live animals, leveraging strong expression to minimize bleaching and observe small",
      "retrieved_chunks": [
        "Title: Illuminating the Sites of Enterovirus Replication in Living Cells by Using a Split-GFP-Tagged Viral Protein\nPassage: transduction, the MLV particles were 5 to 10 times concentrated using a 100-kDa concentrator . For the generation of single-cell clones stably expressing GFP, BGM and HeLa cells were transduced and grown in the presence of puromycin to generate pools of GFP-expressing cells, which were subsequently used to prepare single-cell clones by limiting dilution. Expression of GFP was monitored during passaging by immunofluorescence microscopy using the GFP antibody.\n\nTitle: Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence\nPassage: After application of the overlay, plates were monitored periodically using an inverted fluorescence microscope until the first signs of GFP expression were witnessed . From that time forward, a square subset of the center of each well was imaged periodically, using a CellInsight CX5 High Content Screening Platform with a 4X air objective . Microscope settings were held standard across all trials, with exposure time fixed at 0.0006 s for each image. One color channel was imaged, such that images produced show GFP-expressing cells in white and non-GFP-expressing cells in black .\n\nTitle: Visualizing Viral Infection In Vivo by Multi-Photon Intravital Microscopy\nPassage: express cytoplasmic fluorescent proteins driven e.g., by the chicken \u03b2-actin promoter with cytomegalovirus enhancer or human ubiquitin C promoter . Many different mouse lines are available that contain reporter genes for cytoplasmic fluorescent proteins such as EGFP and mCherry . Due to strong and continuous expression rate of the fluorescent proteins long-term tracking of dividing cells without extensive bleaching is possible. In addition, with a superior signal-to-noise ratio visualization of small cellular structures with low cytoplasm content is feasible. Although the approach to adoptively transfer fluorescent cells of interest into donor mice for functional imaging studies is fast and flexible,\n\nTitle: Replication-Competent Influenza A Viruses Expressing Reporter Genes\nPassage: lungs. Not only was GFP observable in the lungs of infected mice ex vivo using IVIS for whole-organ imaging, but could also be observed using flow cytometry to analyze the infection progression in antigen presenting cells . Imaging of murine lungs showed that infection starts in the respiratory tract in areas close to large conducting airways and later spreads to deeper sections of the lungs . The authors found that using a 10 6 PFU intranasal inoculation, 10% of dendritic cells were observed to express GFP and 2%-3% of macrophages and neutrophils were also GFP+ at 48 h post-infection ."
      ],
      "computed_relevance": 0.4,
      "computed_utilization": 0.4666666666666667,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.21052631578947367,
      "gt_utilization": 0.21052631578947367,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 9,
      "dataset_id": "1261",
      "question": "What's the recommended procedure to disinfect at CT scanner after a COVID-19 exposure?",
      "ground_truth_answer": "The recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves sterilization procedures, noncontaminated CT disinfection procedures, and immediate disinfection of the imaging equipment after the examination.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the recommended procedure to disinfect a CT scanner after a COVID-19 exposure. The context provided has several passages related to CT disinfection procedures. \n\nFirst, I need to look through the given context. The titles all mention emergency management related to COVID-19. The passages mention \"Noncontaminated CT disinfection procedures after suspected COVID-19 case examination\" and \"Fever-CT disinfection procedures after examination.\" Another part says \"equipment and prepares to disinfect the imaging equipment immediately after the examination.\"\n\nSo, putting this together, the key points are that after examining a suspected COVID-19 case, the CT equipment needs to be disinfected. The procedures are referred to as \"Noncontaminated CT disinfection procedures\" and \"Fever-CT disinfection procedures.\" The mention of \"immediately after the examination\" suggests that the timing is right after the exam.\n\nThe answer should probably mention that the recommended procedure involves specific disinfection steps for the CT scanner, possibly using terms like noncontaminated or fever-CT procedures, and that it's done right after the examination. Since the context doesn't go into specific steps like which disinfectants to use, but rather the process, the answer should focus on the procedure being immediate and following established protocols for CT equipment after a suspected case.\n</think>\n\nThe recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves **immediately disinfecting the imaging equipment** following the examination of a suspected or confirmed COVID-19 case. The context emphasizes protocols such as \"noncontaminated CT disinfection procedures\" and \"fever-CT disinfection procedures,\" which likely include decontaminating surfaces, equipment, and ensuring proper sterilization to prevent viral transmission. The process should be carried out promptly after the examination to minimize risk.",
      "retrieved_chunks": [
        "Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Noncontaminated CT disinfection procedures after suspected COVID-19 case examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Fever-CT disinfection procedures after examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: fever-CTs) after these sterilization procedures.\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: equipment and prepares to disinfect the imaging equipment immediately after the examination."
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.5,
      "gt_utilization": 0.5,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    }
  ],
  "skipped_samples": []
}